Catalyst Wire Dossier Catalyst Wire Dossier

Singulair 5 mg chewable tablet

Montelukast · Merck
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Singulair 5 mg chewable tablet, covering 2015-06-24 to 2015-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence Study of Montelukast From Asmakast 5mg Chewable Tab.(Sandoz, Egypt) & Singulair 5mg Chewable Tab.(Merck) [Phase 1]

See pricing